GlaxoSmithKline Plc has spun out technology for the treatment of hearing disorders into a new company called Autifony Therapeutics Ltd. The company is receiving £10 million in Series A funding from Imperial Innovations and SV Life Sciences. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
